Plasma membrane blebs are observed in many types of apoptotic cells, but their physiological roles remain to be clarified. We examined whether there is a causative connection between membrane blebbing and other apoptotic changes in Jurkat cells induced to undergo apoptosis by doxorubicin in the presence or absence of Y-27632, an inhibitor of the Rho kinase ROCK-L The inclusion of the drug made most membrane blebs disappear, while other changes, such as chromatin condensation, inactivation of mitochondrial enzymes, externalization of the membrane phospholipid phosphatidylserine, and removal of cell surface sialic acid, remained unaffected. Furthermore, these apoptotic cells were phagocytosed by macrophages as efficiently as normally apoptosing cells. These results indicate that blebbing of the plasma membrane occurs independently from other apoptotic changes and is not involved in the recognition and engulfment of apoptotic cells by macrophages.
Apoptotic cells are rapidly and selectively eliminated from organisms, and this event is necessary for the maintenance of tissue homeostasis (1) (2) (3) (4) (5) (6) (7) (8) . The phagocytic removal of apoptotic cells is accomplished through an array of distinct biological reactions: migration of phagocytes to the place where apoptotic cells exist, selective recognition and engulfment of target cells by phagocytes, and digestion of engulfed apoptotic cells in phagocytes. Although the importance of this phenomenon is widely accepted, the underlying molecular bases remain mostly unknown.
Among the reactions listed above, the recognition step has been most intensively studied. The surface of apoptotic cells changes structurally and functionally in order for them to be efficiently and selectively recognized by phagocytes (9) (10) (11) . The most obvious change occurs in the composition of phospholipids in the plasma membrane. Phospholipids are distributed asymmetrically in the two leaflets of the membrane bilayer in normal cells (12, 13) , but this asymmetry is disrupted in apoptotic cells through a caspase-dependent mechanism, resulting in the equal distribution of phospholipids in the two leaflets (14, 15) . This change leads to the surface exposure of phospholipids that are otherwise hidden within the cytoplasmic face; phosphatidylserine (PS) is one such phospholipid specifically present at the surface of apoptotic cells and serves as a phagocytosis marker that binds to phagocytes and induces engulfment (14) (15) (16) . Phagocytosis-inducing PS receptors have been identified in various phagocytes such as vascular en-dothelial cells (17) , testicular Sertoli cells (18) , and inflammatory macrophages (19) .
Another change commonly observed at the surface of apoptotic cells is membrane blebbing, a more obvious structural alteration of the plasma membrane. Distinct parts of the membrane of apoptotic cells begin to swell, and apoptotic cells eventually look like raspberries with many "blebs" on their surface (20) . Plasma membrane blebs are thought to serve as the sites for binding of functional molecules such as antigens (21) (22) (23) (24) and phagocytosis markers (25) , and might thus be involved in the recognition and engulfment of apoptotic cells by phagocytes. Although the detailed molecular basis for the formation of blebs remains unknown, the involvement of caspases and a Rho protein kinase, ROCK-I (26, 27) , has been reported (28) (29) (30) . In the present study, we examined the relationship between plasma membrane blebbing and other biochemical and biological changes observed in apoptotic cells using the ROCK-I inhibitor Y-27632 (31, 32) .
MATERIALS AND METHODS
Cell Culture and Apoptosis Analysis-Jurkat cells, human leukemia T-cells, were grown in RPMI 1640 (Nissui Pharmaceutical, Tokyo) containing 10% fetal bovine serum at 37°C in a humidified atmosphere of 5% CO 2 in air. The cells were treated with doxorubicin (Sigma, St. Louis, MO, USA) (1.5 jjLg/ml) to induce apoptosis as described previously (33) . To inhibit apoptosis, the pan-caspase inhibitor z-VAD-fink (Peptide Institute, Osaka, Japan) (20 \xM) was added to the culture 1 h before doxorubicin treatment. The occurrence of membrane blebbing was determined morphoVol. 132, No. 3, 2002 logically by phase-contrast microscopy. For the inhibition of membrane Webbing, cells were pre-treated with Y-27632 (a gift from Mitsubishi Welpharma, Tokyo) 1 h before the induction of apoptosis. Plasma membrane permeability, the activity of mitochondrial enzymes, chromatin condensation, and DNA fragmentation were determined by standard procedures: a dye exclusion assay with trypan blue, an enzyme assay using 3-(4,5-dimethyl-2-thyazolyl)-2,5-diphenyl-2H-tetrazolium bromide (Dojin, Kumamoto) (MTT assay), staining with Hoechst 33342, and agarose gel electrophoresis, respectively (33) . PS externalization and the loss of cell surface sialic acid were examined by flow cytometry (EPICS-XL; Beckman Coulter, Miami, FL, USA) using fluorescence-labeled annexin V and sialic acid-recognizing lectins, respectively (34, 35 Western Blotting-Jurkat cells were lysed in a buffer containing 50 mM Tris-HCl (pH 7.5), 1% Triton X-100, 0.1 M NaCl, and a protease inhibitor cocktail (Sigma), incubated on ice for 30 min, and centrifuged at 18,000 xg for 10 min at 4°C. The solubilized proteins were electrophoretically separated on a 10% SDS-polyacrylamide gel and transferred onto a polyvinylidene difluoride membrane (Tmmnbilon P; Millipore, Bedford, MA, USA). The membrane was blocked with 5% dry skim milk, reacted successively with anti-human ROCK-I antibody (C-17 or K-18; Santa Cruz Biotechnology, Santa Cruz, CA, USA) and alkaline phosphatase-conjugated anti-goat IgG (Bio-Rad Laboratories, Hercules, CA, USA), and chemiluminescently analyzed for signals using Immun-Star substrates (Bio-Rad). To examine the specificity of the antibody reactions, the first antibody was pre-incubated with an excess amount of the corresponding antigen peptide (Santa Cruz Biotechnology).
Macrophage Preparation and Phagocytosis Assay-Macrophages were prepared from peritoneal fluids of thioglycollate-injected BDF X mice (female, 8-12 weeks old) and cultivated on coverslips until use as described previously (33, 38) . The phagocytosis assay was performed essentially as described (33, 38) . Briefly, apoptotic Jurkat cells were mixed with macrophages at a ratio of 10 target cells to one macrophage, and incubated at 37°C for various lengths of time. The mixture was treated with trypsin to remove target cells lightly attached to macrophages. The remaining macrophages were fixed with paraformaldehyde, permeabilized with methanol, and stained with hematoxylin. The numbers of macrophages with engulfed Jurkat cells and the number of engulfed cells present in each macrophage were determined by examination under a light microscope. The scores were expressed relative to the total number of macrophages (in percentage; the phagocytdc index) and per 100 macrophages, respectively, as the mean and SD of a (1.5ug/ml) (100 uM) typical example from at least three independent experiments. Iiposomes composed of a combination of phosphatidylchohne and PS at a ratio of 7:3 were prepared as described previously (34) .
RESULTS

Inhibition of Membrane Blebbing by ROCK-I
Inhibitor Y-27632-Jurkat cells were induced to undergo apoptosis by treatment with doxorubicin and examined for the occurrence of plasma membrane blebbing (Fig. 1) . Distinct parts of the cell periphery protruded like balloons (Fig. IB) which became evident 18 h after doxorubicin addition and continued to increase thereafter (left panel in Fig. 1A) . These results indicate that treatment with doxorubicin effectively induces plasma membrane blebbing in Jurkat cells. This change in the structure of the plasma membrane almost completely disappeared when Jurkat cells were incubated with the pan-caspase inhibitor z-VAD-fmk prior to the addition of doxorubicin (middle panel in Fig. 1A) . Furthermore, the ROCK-I inhibitor Y-27632 showed a similar inhibitory effect on membrane blebbing in a dose-dependent manner (middle and right panels in Fig. 1A and Fig. IB) . These results indicate that plasma membrane blebbing in apoptotic Jurkat cells depends on the activity of both caspases and ROCK-I, and this accords well with previous observations using other types of cells and apoptosis inducers (29, 30, (39) (40) (41) .
ROCK-I is activated by the caspase-mediated cleavage of its C-terminal region in apoptotic cells (29, 30) . In order to verify that this occurs in doxorubicin-treated Jurkat cells, whole-cell lysates were analyzed by Western blotting with anti-ROCK-I antibody (Fig. 2) . A signal with a molecular mass of about 160 kDa was detected, and its intensity decreased during apoptosis (top panel in Fig. 2A ). This signal resulted from the specific reaction with the antibody, since the inclusion of the corresponding antigen peptide in the antibody reaction completely eliminated the signal (bottom panel in Fig. 2A ). These results indicate that the amount of the intact form of ROCK-I decreases during apoptosis, most probably due to cleavage by caspases. This change was abrogated, though incompletely, by the addition of z-VADfmk (top panel in Fig. 2B ), but, unexpectedly, ROCK-I appeared to be cleaved after the induction of apoptosis even in cells pre-treated with Y-27632 (bottom panel in Fig. 2B ). These results conflict with previous observations that ROCK-I does not undergo cleavage in the presence of Y-27632 (29, 30) , and suggest that the inhibition of plasma membrane blebbing by Y-27632 is achieved through a mechanism other than interference with the activation of ROCK-I.
No Effect of Y-27632 on Other Biochemical Apoptotic Changes-We examined whether or not the presence of Y-27632 inhibits other biochemical apoptotic changes in doxorubicin-treated cells. The condensation of chromatin ( Fig.  IB and Fig. 3A) , inactivation of mitochondrial enzymes (Fig. 3B) , and externalization of PS (Fig. 3C ) all occurred normally even in the presence of Y-27632. In addition, the drug did not affect the removal of cell surface sialic acid, which was evident from a decrease in the amount of sialic acid-recognizing lectins bound to cells. Essentially the same results were obtained with three different lectins, WGA, MAM, and SAS (Fig. 3D) .
No Effect of Membrane Blebbing on Susceptibility to
Phagocytosis-We previously reported that doxorubicintreated Jurkat cells are phagocytosed by thioglycoilateinduced mouse peritoneal macrophages in a manner partly mediated by PS expressed on the surface of target cells during apoptosis (33) . The removal of cell surface sialic acid, another change that occurs at the surface of apoptotic cells, has been shown to be necessary for efficient phagocytosis (35). We therefore examined whether or not the presence of plasma membrane blebs is involved in the phagocytosis of apoptotic cells by macrophages. To do so, the phagocytosis assay was conducted with Jurkat cells that had been induced to undergo apoptosis by doxorubicin with and without Y-27632 pre-treatment (Fig. 4) . The extent of phagocytosis was determined based on the ratio of macrophages that accomplished phagocytosis or on the number of engulfed cells in each macrophage. Cells pre-treated with Y-27632 were phagocytosed with a time course and efficiency similar to those of normally apoptosing cells using either criterion (Fig. 4A) . Phagocytosis was partly inhibited by the addition of PS-containing Iiposomes, and the extent of inhibition was almost equal in reactions with apoptotic Jurkat cells treated or not treated with Y-27632 (Fig. 4B ). This indicates that plasma membrane blebbing is not involved in phagocytosis either mediated or not mediated by cell surface PS. 
DISCUSSION
Plasma membrane blebbing is one of the hallmarks of apo ptosis, but its mechanism and physiological consequences remain to be elucidated. In the present study, we examined whether there is a causative connection between membrane blebbing and other intracellular as well as surface changes evident during apoptosis. For this purpose, chromatdn condensation, inactivation of mitochondrial enzymes, PS externalization, and cell surface desialylation were determined in apoptotic Jurkat cells treated with a drug that completely inhibits plasma membrane blebbing. We found that all of these biochemical changes occurred in apoptotic cells with no blebs on the plasma membrane. This clearly indicates that plasma membrane blebbing does not occur upstream of these changes in the apoptotic pathway. Both caspase-dependent and -independent mechanisms seem to be responsible for blebbing of the plasma membrane (29, 30, (40) (41) (42) (43) (44) . Our results show that the appearance of membrane blebs in doxorubicin-treated Jurkat cells depends on caspases and is completely inhibited by the ROCK-I inhibitor Y-27632. However, the cleavage of ROCK-I, which reportedly leads to the activation of this protein kinase, was evident even in the presence of Y-27632. This was also the case when another apoptosis inducer, an agonistic anti-Fas antibody, was used to kill Jurkat cells (data not shown). Given that Y-27632 specifically targets ROCK-I, the drug might abrogate the function of ROCK-I not by inhibiting the partial cleavage in the inactive precursor, but by inhibiting the action of the cleaved and thus activated ROCK-I. However, this is only speculative, and further studies are needed to resolve the issue. Plasma membrane blebbing is a change that occurs at the surface of apoptotic cells in addition to alterations in the composition of phospholipids and the structure of sugar moieties. Among the surface changes reported so far, PS externalization and desialylation make apoptotic cells more susceptible to phagocytosis, an important biological consequence of apoptosis. Inhibition of plasma membrane blebbing did not influence the extent of either PS externalization or desialylation, indicating that the latter two changes occurring at the surface of apoptotic cells are unrelated to membrane blebs. Furthermore, apoptotic Jurkat cells with and without membrane blebs were equally phagocytosed by macrophages, and the addition of PS-containing liposomes inhibited phagocytosis of apoptotic Jurkat cells treated or not treated with Y-27632 to similar extents. These results indicate that plasma membrane blebs are not involved in phagocytosis either mediated or not mediated by PS. The PS-independent reactions in our assay do not seem to require factors present in serum, because the efficiency of phagocytosis was the same for reactions with and without serum (data not shown). Therefore, it remains possible that membrane blebs play a role in complement-or Fc-mediated recognition of apoptotic cells by phagocytes. In fact, Clq preferentially binds to apoptotic cells at plasma membrane blebs (45). Apart from phagocytosis, membrane blebs could be involved in the transmission of signals from apoptotic cells to their neighbors, as shown with apoptotic epithelial cells extruded from the epithelium {46). Further studies from various points of view will be necessary to clarify the physiological consequences of plasma membrane blebbing.
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